2016-09-01
Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1
Publication
Publication
Journal of Clinical Oncology , Volume 34 - Issue 25 p. 3005- 3013
Additional Metadata | |
---|---|
doi.org/10.1200/JCO.2015.65.5597, hdl.handle.net/1765/97104 | |
Journal of Clinical Oncology | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Smith, M. (Matthew), de Bono, J., Sternberg, C., Moulec, S.L. (Sylvestre Le), Oudard, S., de Giorgi, U., … Fizazi, K. (2016). Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1. In Journal of Clinical Oncology (Vol. 34, pp. 3005–3013). doi:10.1200/JCO.2015.65.5597 |